China Shineway Pharmaceutical Group Limited

CSWYFOTCHealthcare● Active

$1.08

+$0.08(+7.57%)

Market Cap$815832000

P/E Ratio—

52W High$1.08

52W Low$0.9253

Avg Volume50.8

Open$1.00

Beta0.71

Net Income Financials Revenue

China Shineway Pharmaceutical Group Limited (CSWYF) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

CSWYF · net income · updated Jun 9, 2026

Core profitability metrics

CSWYF · net income · margin · TTM · CAGR

Net income was $949.9M for FY2025 (fiscal year ending 2025-12-31), up 13.1% year-over-year. Net profit margin was 30.3%. Based on available data, China Shineway Pharmaceutical Group Limited has been profitable since at least 2015.

FY2025 Net Income$949.9M▲ +13.1% YoY

Trailing 12M (TTM)$1.87Btrailing 4 quarters sum

Net Profit Margin30.3%$949.9M ÷ $3.14B

YoY Change+13.1%—

5-Year CAGR+27.8%FY2020 → FY2025

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2015

▸ FMP /income-statement · Annual · CSWYF net income history · CSWYF profit margin

Annual net income data

CSWYF · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025$949.9M▲ +13.1%30.3%$3.14B

FY2024$840.1M▼ 13.5%22.2%$3.78B

FY2023$971.6M▲ +31.8%3.0%$32.00B

FY2022$737.2M▲ +32.4%18.3%$4.03B

FY2021$556.7M▲ +99.5%17.6%$3.17B

Net income vs peers (Healthcare)

CSWYF vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

China Shineway Pharmaceutical Group LimitedYOU

CSWYF

$949.9M+13.1%30.3%

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

China Shineway Pharmaceutical Group Limited (CSWYF) reported net income of $949.9M for FY2025 (fiscal year ending 2025-12-31), up 13.1% year-over-year. The net profit margin was 30.3% — meaning the company kept $0.30 of every dollar of revenue as profit.

Based on available data, China Shineway Pharmaceutical Group Limited has been profitable since at least 2015. Net income reached a peak of $971.6M in FY2023. Data available for 11 fiscal years.

China Shineway Pharmaceutical Group Limited's net profit margin was 30.3% for FY2025, based on the latest annual results.

Investors sometimes search for "China Shineway Pharmaceutical Group Limited net worth" — the company's market capitalization is a separate figure from CSWYF net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

CSWYF net income · 5 questions

China Shineway Pharmaceutical Group Limited is profitable. The company reported net income of $949.9M for FY2025, a net profit margin of 30.3%. Net income was up 13.1% year-over-year. Based on available data, China Shineway Pharmaceutical Group Limited has been profitable since at least 2015.

is CSWYF profitabledoes CSWYF make a profitCSWYF profitabilityCSWYF profitable company

▸ Source: FMP /income-statement · GAAP · China Shineway Pharmaceutical Group Limited · China Shineway Pharmaceutical Group Limited SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026